Important Safety Information
Who should not use Essure

Essure is contraindicated in patients who are uncertain about ending fertility, can have only one insert placed (including contralateral proximal tubal occlusion or suspected unicornuate uterus), have previously undergone a tubal ligation, are pregnant or suspect pregnancy, delivered or terminated a pregnancy less than 6 weeks prior to the Essure procedure, have an active or recent upper or lower pelvic infection, or have a known allergy to contrast media. Continue reading below

With 99.83% efficacy*, Essure is the only FDA-approved permanent birth control with a procedure that can be performed in an office setting without general anesthesia.

*Based on 5-year clinical study data.

Watch the Essure Procedure Video Now.

After hysteroscopically assessing both ostia for patency and accessibility, insert the introducer through the sealing cap of the scope's working channel. Your assistant may initially thread the Essure device through the introducer while you hold the hysteroscope. Once the Essure system is advanced halfway, take over advancing the catheter. The dry flow introducer remains in the working channel throughout the procedure. Slowly and steadily advance the Essure delivery system into the fallopian tubes. Advance until the black positioning marker reaches the tubal ostium. Use one hand to stabilize the Essure system handle against the hysteroscope camera. This prevents inadvertent movement of the Essure system. With the black marker still at the ostium, rotate the thumbwheel back to a hard stop on the catheter handle. This step is inscribed as '1' on the handle as a reminder. You will see the black marker move towards the hysteroscope. This is normal. Depicted as step 2 on the handle, stop and check the positioning of the Essure system. The gold band should be seen just outside the ostium. The distal tip of the green release catheter should just be in view. The wound down micro insert should be exposed. If necessary, reposition the Essure catheter so that the gold band is just outside the tubal ostium. Corresponding to the inscribed symbol '3,' press the button on the system handle. As depicted by symbol ‘4’, rotate the thumbwheel back to a hard stop. This expands the outer coils, and detaches the Essure microinsert. Withdraw the Essure system, and document the number of proximal coils for your records.

With 99.83% efficacy,*
Essure is the only FDA-approved permanent birth control with a procedure that can be performed in an office setting without general anesthesia.

*Based on 5-year clinical study data.

Watch the Essure Procedure Video Now.

Which Patients May Be Right for Essure?

Get the facts

Request a Bayer Sales Consultant

Submit your request

Offer Essure in the office setting

Get started


Essure is indicated for women who desire permanent birth control (female sterilization) by bilateral occlusion of the fallopian tubes.

Important Safety Information

Prescription Only

Caution: Federal law restricts this device to sale by or on the order of a physician. Device to be used only by physicians who are knowledgeable hysteroscopists; have read and understood the Instructions for Use and Physician Training manual; and have successfully completed the Essure training program, including preceptoring in placement until competency is established, typically 5 cases.

Who Should Not Use Essure

Pregnancy Considerations

Procedural Considerations

Nickel Allergy

Patients who are allergic to nickel may have an allergic reaction to this device, especially those with a history of metal allergies. In addition, some patients may develop an allergy to nickel if this device is implanted. Typical allergy symptoms reported for this device include rash, pruritus, and hives.

MRI Information

The Essure insert was determined to be MR-conditional according to the terminology specified in the American Society for Testing and Materials (ASTM) International, Designation: F2503-05.

Clinical Trial Experience

This product does not protect against HIV infection or other sexually transmitted diseases.

Report any adverse events or product technical complaints involving the Essure® product to Bayer Healthcare LLC immediately by calling 888-84-BAYER (888-842-2937).

You are also encouraged to report negative side effects or quality complaints of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.